GlassScriptPhysician profile
Katherine E Sapienza
NPI 1326757568
$1,414.81
in general payments reported to CMS, 2019-2025
18 companies · $596 in 2025
The $596 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $291 · 2024: $528 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $308.70 | 2023-2025 | Slynd |
| Amgen INC. | $298.74 | 2024-2025 | Evenity, Prolia, Prolia |
| Biogen, INC. | $137.11 | 2024-2025 | Zurzuvae |
| Organon LLC | $133.50 | 2023-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $100.17 | 2025 | |
| Sumitomo Pharma America, INC. | $52.27 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $48.10 | 2023-2025 | |
| Millicent US INC | $45.77 | 2024-2025 | Femlyv, Intrarosa |
| Hologic Sales and Service, LLC | $43.74 | 2024-2025 | Thinprep 2000 Processor |
| Coopersurgical, INC. | $42.43 | 2024-2025 | Paragard T 380a |
| Boston Scientific Corporation | $40.23 | 2025 | Bulkamid |
| Axonics, INC. | $35.24 | 2023 | Bulkamid |
| Pfizer INC. | $27.12 | 2025 | |
| Daiichi Sankyo INC. | $22.55 | 2023 | Injectafer |
| Astellas Pharma US INC | $21.67 | 2024 | Veozah |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $20.01 | 2024 | Twirla |
| Smith+Nephew, INC. | $19.24 | 2025 | Allevyn Life L 15.4x15.4 Ctn10 |
| Davol INC. | $18.22 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Sapienza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.